Cargando…
Mucins in ovarian cancer diagnosis and therapy
Ovarian cancer is the most lethal gynecologic malignancy and the five-year survival rate is only 35% after diagnosis. Epithelial ovarian cancer is a highly metastatic disease characterized by widespread peritoneal dissemination and ascites. The death incidences from ovarian cancer could be significa...
Autores principales: | Chauhan, Subhash C, Kumar, Deepak, Jaggi, Meena |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2804676/ https://www.ncbi.nlm.nih.gov/pubmed/20034397 http://dx.doi.org/10.1186/1757-2215-2-21 |
Ejemplares similares
-
Current status and implications of microRNAs in ovarian cancer diagnosis and therapy
por: Zaman, Mohd Saif, et al.
Publicado: (2012) -
Scope of nanotechnology in ovarian cancer therapeutics
por: Yallapu, Murali M, et al.
Publicado: (2010) -
miR-205: A Potential Biomedicine for Cancer Therapy
por: Chauhan, Neeraj, et al.
Publicado: (2020) -
Gemcitabine Combination Nano Therapies for Pancreatic Cancer
por: Samanta, Kamalika, et al.
Publicado: (2019) -
Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth
por: Yallapu, Murali M, et al.
Publicado: (2010)